Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Marty Makary departs FDA after clashes with Trump over fruit-flavored vapes

Kyle Diamantas, a top official at the agency, will replace Makary and serve as acting FDA commissioner

The Guardian - US

SAB Biotherapeutics Q1 Earnings Call Highlights

SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the clinical-stage biopharmaceutical company reported a wider first-quarter loss alongside higher research and development spending. Chief Executive Officer Sa

MarketBeat

Makary out at FDA after facing pressure to resign

Food and Drug Administration Commissioner Marty Makary will leave his role, President Donald Trump said Tuesday. Makary’s departure comes after pressure within the administration to step down over a variety of issues, from abortion medication to flavored vapes. FDA Deputy Commissioner for Food Kyle Diamantas will lead the agency in an acting capacity. He…

Roll Call

From analysis to the latest developments in health,
read the most diverse news in one place.

Target snack mix among products recalled over potential salmonella contamination

The recall includes a Good & Gather product that was sold at Target stores across the US

The Independent UK

Arvinas Q1 Earnings Call Highlights

Arvinas (NASDAQ:ARVN) said its first quarter was marked by the FDA approval of VEPPANU, a new licensing agreement with Rigel Pharmaceuticals and continued progress across a clinical-stage pipeline focused on targeted protein degradation. President and Chief Executive Officer Randy Teel said the app

MarketBeat

Achieve Life Sciences Q1 Earnings Call Highlights

Achieve Life Sciences (NASDAQ:ACHV) used its first-quarter 2026 earnings call to outline a transition period marked by new leadership, a major financing, manufacturing changes tied to its cytisinicline regulatory timeline and preparations for a potential commercial launch in 2027. Dr. Andrew Goldbe

MarketBeat

Europe’s best-performing stocks of 2026 — including one up by 947%

From Swedish photonics to French satellites and British fuel cells, meet this year's top-performing equities across sectors.

Euronews

Read news from The Economist, FT, and more,
with one subscription

Hims & Hers Health Q1 Earnings Call Highlights

Hims & Hers Health (NYSE:HIMS) reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company’s weight-loss business is creating short-term margin pressure and volatility in GAAP results. On the company’s earnings call

MarketBeat

aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial

aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C meeting. President and CEO Dr. Sanjay Shukla said the meeting, held in mid-April with official minu

MarketBeat

Report: FDA Commissioner Set To Be Fired, Sources Say Trump Could Still Change His Mind

Makary is scheduled to testify before the Senate Appropriations Committee on May 13 on the FDA's budget for the coming fiscal year. He was appointed to his post last year.

Latin Times

Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what investors need to know

Hims stock after Hims & Hers earnings: Hims & Hers Health shares dropped significantly after reporting a surprise first-quarter loss and revenue below expectations. Despite these weak results, the company raised its full-year revenue outlook and projected strong second-quarter revenue, as it navigates regulatory scrutiny around weight-loss drugs.

The Economic Times

Justice Alito Extends Administrative Stay of Mifepristone Order

The justices will consider what to do with the Fifth Circuit's mifepristone order for af ew more days

Reason

Supreme Court Maintains Temporary Mail Access To Abortion Pill Mifepristone

The Supreme Court extended temporary mail access to abortion pill mifepristone on Monday.

International Business Times

US supreme court temporarily extends access to mail-order abortion medication mifepristone

Louisiana had sued the FDA last fall, arguing that prescribing mifepristone interfered with state’s ban on abortion

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study

Alpha Tau Medical (NASDAQ:DRTS) presented early clinical results from the first three patients treated in its REGAIN study of Alpha DaRT for recurrent glioblastoma, with company executives and clinical investigators describing initial tumor responses and safety observations from the pilot trial. Th

Axios

FDA cliffhanger: Will Marty Makary stay or go?

The stable part of President Trump's health bureaucracy has turned into a soap opera.

Grocery Coupon Guide

12 States Where You Can Get Free Produce Through Their USDA Supported Farmers Market Nutrition Programs

Access to fresh seasonal produce is a fundamental requirement for maintaining a healthy and vibrant lifestyle. Many low-income seniors and families struggle to afford the premium prices found at boutique grocery stores. The federal government partners with specific states to provide free produce vouchers through a dedicated nutrition initiative. These…

Grocery Coupon Guide

12 Signs That You Have Been Food Poisoned At The Restaurant You Just Ate At

Eating out with friends should be a relaxing break from your busy daily routine. However, sometimes a contaminated meal can turn a pleasant evening into a medical emergency. Recognizing the physical warning signs of food poisoning is critical for your long-term recovery. Many symptoms appear within just a few hours…

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Health advocates warn government’s claims of baby formula safety contradict data

Independent scientists who reviewed the results said most samples were contaminated with Pfas or phthalates

International Business Times

FDA Extends Review of Eisai, Biogen Alzheimer's Drug

The agency pushed its decision on weekly subcutaneous LEQEMBI IQLIK for early Alzheimer's initial treatment to Aug. 24 after seeking additional information.

LiveScience

Science news this week: The latest on the cruise ship hantavirus infections, a shortcut to Mars, and a fast-charging quantum battery

May 9, 2026: Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the weekend

The Guardian - US

‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummets

Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs

Reason

The Mifepristone Briefs Are In, But One Dog Did Not (Yet) Bark

It appears the Supreme Court will decide the fate of telemedicine prescriptions for mifepristone without the benefit of an FDA filing.

Bangkok Post

Tests confirm tilapia in mackerel cans

The Fisheries Department has confirmed that canned fish products labelled as mackerel in Samut Sakhon were found to contain pla nil (tilapia), not mackerel as stated on the packaging.

The Texas Tribune

What to know about the federal rule that Texans have used to mail in abortion pills

In 2023, the Food and Drug Administration started allowing mifepristone to be delivered by mail. The federal courts are deciding whether to pull that permission.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

the Wall Street Journal

1,315 stories

Fifth Circuit

362 stories

Food and Drug Administration

347 stories

the Fifth Circuit

222 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.